Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis
Journal of Benefit-Cost Analysis · 2019 · 10 (S1) · 15-50
DOI: 10.1017/bca.2018.26 ↗At a glance
Journal article in Journal of Benefit-Cost Analysis, published online on 2019-01-15. Written by Lisa A Robinson and 2 co-authors. Institution: Harvard T.H. Chan School of Public Health, Center for Health Decision Science and Center for Risk Analysis, 718 Huntington Avenue, Boston, Massachuse…. Cited 192 times so far (Crossref); 75 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
The estimates used to value mortality risk reductions are a major determinant of the benefits of many public health and environmental policies. These estimates (typically expressed as the value per statistical life, VSL) describe the willingness of those affected by a policy to exchange their own income for the risk reductions they experience. While these values are relatively well studied in high-income countries, less is known about the values held by lower-income populations. We identify 26 studies conducted in the 172 countries considered low- or middle-income in any of the past 20 years; several have significant limitations. Thus there are few or no direct estimates of VSL for most such countries. Instead, analysts typically extrapolate values from wealthier countries, adjusting only for income differences. This extrapolation requires selecting a base value and an income elasticity that summarizes the rate at which VSL changes with income. Because any such approach depends on assumptions of uncertain validity, we recommend that analysts conduct a standardized sensitivity analysis to assess the extent to which their conclusions change depending on these estimates. In the longer term, more research on the value of mortality risk reductions in low- and middle-income countries is essential.
Subjects
Author keywords
Authors and institutions
- Harvard T.H. Chan School of Public Health, Center for Health Decision Science and Center for Risk Analysis, 718 Huntington Avenue, Boston, Massachusetts 02115, USA.
- Toulouse School of Economics, Université Toulouse Capitole, 21, allée de Brienne, 31000 Toulouse, France.
Cite
APA
Robinson, L. A., Hammitt, J. K., & O'Keeffe, L. (2019). Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis. Journal of Benefit-Cost Analysis, 10(S1), 15-50. https://doi.org/10.1017/bca.2018.26
Vancouver
Robinson LA, Hammitt JK, O'Keeffe L. Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis. Journal of Benefit-Cost Analysis. 2019;10(S1):15-50. doi:10.1017/bca.2018.26
BibTeX
@article{Robinson2019,
author = {Robinson, Lisa A and Hammitt, James K and O'Keeffe, Lucy},
title = {Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis},
journal = {Journal of Benefit-Cost Analysis},
year = {2019},
volume = {10},
number = {S1},
pages = {15--50},
doi = {10.1017/bca.2018.26}
}
EUVIMED